Aclarion Technology Demonstrates Potential Beyond Surgical Planning in New Immune-Biomarker Study
PR Audio: BROOMFIELD, Colo., June 1, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a commercial-stage healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, today announced […]
PRISM MarketView Spotlights Seven Public Companies Advancing Mental Health Innovation During National Mental Health Awareness Month
Growing investor interest in brain health, workplace resilience, and next-generation mental health treatments PR Audio: NEW YORK, May 26, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – PRISM MarketView, the financial media platform serving active retail and self-directed investors, today highlighted seven public companies developing therapies, devices, and digital platforms aimed at […]
BioStem Strengthens Leadership Team with Appointment of Katherine Gorrell as Chief Legal & Compliance Officer
Adds accomplished legal and compliance executive with two decades of experience advising healthcare organizations through complex regulatory, governance, and growth initiatives Pompano Beach,Fla, April 30, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – BioStem Technologies (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacturing and commercialization of perinatal […]
Aclarion Appoints Daniel Keefe as Commercial Director, Western U.S., to Drive Continued Adoption of Nociscan
BROOMFIELD, Colo., April 28, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – Aclarion, Inc. (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, today announced the appointment of Daniel […]
SS Innovations Unveils Cutting-Edge Surgical Robotic Technologies at SMRSC 2026
Innovations under development by Company include the SSi Vimana Aero, SSi Avtara and SSi Operion Fort Lauderdale, FL, April 23, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery […]
Aclarion Announces $2.5 Million Stock Repurchase Plan
Highlights Disciplined Capital Allocation While Supporting Continued Nociscan® Adoption Broomfield, CO, April 22, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a commercial-stage healthcare technology company leveraging biomarkers and proprietary augmented intelligence (AI) algorithms through its Nociscan platform to help physicians identify the location […]
Aclarion Secures U.S. Patent Advancing Scalable, AI-Driven Assessment of Chronic Low Back Pain
Broomfield, CO, April 16, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a commercial-stage healthcare technology company leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, today announced the issuance of U.S. Patent #12,601,803, […]
Aclarion Receives Pinnacle Award for AI Innovation
Recognition Follows 2025 HLTH Digital Health Award for Nociscan Award Winning AI Targets a Large and Costly Chronic Low Back Pain Market Broomfield, CO, April 14, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a commercial-stage healthcare technology company that is leveraging biomarkers and […]
Aclarion Announces Agreement with Weill Cornell Medicine
Expands use of Nociscan in groundbreaking trial Broomfield, CO, April 8, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a commercial-stage healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back […]
Aclarion Highlights Growing Adoption of Nociscan at The London Clinic with New Physician Video
BROOMFIELD, Colo., April 07, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a commercial-stage healthcare technology company leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, today announced the release of a new video featuring […]